Human Pathology Neoplasia

Clinical Aspects: Grading, Staging, and Paraneoplastic Syndromes​

Topic overview

Start with the big picture

Grading evaluates features such as differentiation, nuclear atypia, mitotic activity, and necrosis; lower-grade tumors are generally more differentiated and associated with a better prognosis. Staging assesses anatomic spread and is generally more important for prognosis. The TNM framework describes the primary tumor, regional lymph nodes, and distant metastasis, with stages grouped from 0 to IV. Paraneoplastic syndromes result from mechanisms such as ectopic hormone or cytokine production, immune cross-reactivity, and hypercoagulability. Examples include endocrine disturbances, neuromuscular effects, skin changes, and thrombotic complications. Some syndromes can appear before a tumor is identified, making recognition of the pattern clinically relevant.

Learning objectives

What you'll learn

  • Distinguish histologic grading from anatomic staging.
  • Identify the features used to assess tumor grade.
  • Describe the T, N, and M components of TNM staging.
  • Recognize common mechanisms and clinical patterns of paraneoplastic syndromes.
Ready for the complete lesson?

Continue your study

Work through the complete notes and reinforce the topic with the study tools available in the full lesson.

PharmaProLearn

Excel Beyond Limits